Esc, a compound with potential anticancer properties, promotes apoptosis and inhibits the proliferation of tumor cells
Esc, a compound with potential anticancer properties, promotes apoptosis and inhibits the proliferation of tumor cells. These effects are mediated by various molecular mechanisms involving different signaling pathways. In the PI3K/Akt pathway, Esc modulates the upstream molecule, IGF-1, to regulate the PI3K/Akt pathway in gastric cancer cells. Esc also targets downstream mTOR molecules to induce apoptosis and cell cycle arrest. Esc induces G1 phase cell cycle arrest by upregulating Ras, ERK1/2 and p27 KIP8, and activates MAPK signaling to induce apoptosis in colon and bladder cancer cells. Esc also regulates NF-κB in lung cancer cells. Esc activates the ARE pathway in pancreatic cancer cells by disrupting the Nrf2-KEAP1 interaction. Esc decreased Sp1 expression in oral squamous cell carcinoma cells and enhances TRAIL-induced apoptosis in oral cancer cells by upregulating DR5. Esc regulates the JAK/STAT3 pathway in ovarian and laryngeal cancers, leading to decreased expression of MMP2 and MMP9. In the Wnt/β-catenin pathway, Esc downregulates proteins such as c-Myc and cyclin D1, binds directly to β-catenin and inhibits the β-catenin/Tcf complex. Esc binds to hnRNPA1 in endometrial cancer, affecting Bcl-xl expression. These pathways highlight the diverse mechanisms through which Esc inhibits cancer proliferation and suggest its potential as a targeted therapy for various cancer types. Esc, esculetin; ERK, extracellular signal-regulated kinase; JAK, janus kinase; STAT3, signal transducer and activator of transcription-3; Nrf2, nuclear factor erythroid 2-related factor 2; MMP, matrix metalloproteinase; NF-κB, nuclear factor-κB; Sp1, specificity protein 1; DR, death receptor; MEK, mitogen-activated protein kinase kinase; hnRNPA1, heterogeneous nuclear ribonucleoprotein A1
Publication
Therapeutic potential of esculetin in various cancer types (Review) (2024) Mengying Liu, et al. Oncol Lett. 2024 Jul;28(1). Figure: F2.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CA | 5290 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CB | 5291 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CD | 5293 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CG | 5294 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R3 | 8503 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R4 | 30849 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R5 | 23533 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R6 | 146850 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R1 | 5295 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R2 | 5296 |
| Homo sapiens | Primates | IGF-1 | IGF1 | ncbigene_symbol | IGF1 | 3479 |
| Homo sapiens | Primates | Ras | RAS | famplex_relations | KRAS | 3845 |
| Homo sapiens | Primates | Ras | RAS | famplex_relations | HRAS | 3265 |
| Homo sapiens | Primates | Ras | RAS | famplex_relations | NRAS | 4893 |
| Homo sapiens | Primates | JNK | JNK | ncbigene_synonym | MAPK8 | 5599 |
| Homo sapiens | Primates | JNK | JNK | famplex_relations | MAPK9 | 5601 |
| Homo sapiens | Primates | JNK | JNK | famplex_relations | MAPK10 | 5602 |
| Homo sapiens | Primates | AKT | AKT | ncbigene_synonym | AKT1 | 207 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT2 | 208 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT3 | 10000 |
| Homo sapiens | Primates | p38 | P38 | ncbigene_synonym | CRK | 1398 |
| Homo sapiens | Primates | p38 | P38 | ncbigene_synonym | MAPK14 | 1432 |
| Homo sapiens | Primates | p38 | P38 | ncbigene_synonym | MAPK1 | 5594 |
| Homo sapiens | Primates | p38 | P38 | ncbigene_synonym | AIMP2 | 7965 |
| Homo sapiens | Primates | p38 | P38 | ncbigene_synonym | GRAP2 | 9402 |
| Homo sapiens | Primates | p38 | P38 | ncbigene_synonym | AHSA1 | 10598 |
| Homo sapiens | Primates | p38 | P38 | ncbigene_synonym | POLDIP2 | 26073 |
| Homo sapiens | Primates | p38 | P38 | famplex_relations | MAPK11 | 5600 |
| Homo sapiens | Primates | p38 | P38 | famplex_relations | MAPK12 | 6300 |
| Homo sapiens | Primates | p38 | P38 | famplex_relations | MAPK13 | 5603 |
| Homo sapiens | Primates | MAPK | MAPK | famplex_relations | MAPK3 | 5595 |
| Homo sapiens | Primates | MEK | MEK | ncbigene_synonym | MAP2K7 | 5609 |
| Homo sapiens | Primates | MEK | MEK | famplex_relations | MAP2K1 | 5604 |
| Homo sapiens | Primates | MEK | MEK | famplex_relations | MAP2K2 | 5605 |
| Homo sapiens | Primates | KEAP1 | KEAP1 | ncbigene_symbol | KEAP1 | 9817 |
| Homo sapiens | Primates | Nrf2 | NRF2 | ncbigene_synonym | GABPA | 2551 |
| Homo sapiens | Primates | Nrf2 | NRF2 | ncbigene_synonym | NFE2L2 | 4780 |
| Homo sapiens | Primates | STAT3 | STAT3 | ncbigene_symbol | STAT3 | 6774 |
| Homo sapiens | Primates | PERK | PERK | ncbigene_synonym | EIF2AK3 | 9451 |
| Homo sapiens | Primates | mTOR | MTOR | ncbigene_symbol | MTOR | 2475 |
| Homo sapiens | Primates | p21 | P21 | ncbigene_synonym | CDKN1A | 1026 |
| Homo sapiens | Primates | p21 | P21 | ncbigene_synonym | TCEAL1 | 9338 |
| Homo sapiens | Primates | p21 | P21 | ncbigene_synonym | NSG1 | 27065 |
| Homo sapiens | Primates | p21 | P21 | ncbigene_synonym | H3P16 | 644914 |
| Homo sapiens | Primates | DR5 | DR5 | ncbigene_synonym | TNFRSF10B | 8795 |
| Homo sapiens | Primates | JAK1 | JAK1 | ncbigene_symbol | JAK1 | 3716 |
| Homo sapiens | Primates | JAK2 | JAK2 | ncbigene_symbol | JAK2 | 3717 |
| Homo sapiens | Primates | MMP-2 | MMP-2 | ncbigene_synonym | MMP2 | 4313 |
| Homo sapiens | Primates | MMP-9 | MMP-9 | ncbigene_synonym | MMP9 | 4318 |
| Homo sapiens | Primates | B-catenin | CTNNB1 | ncbigene_symbol | CTNNB1 | 1499 |
| Homo sapiens | Primates | NF-kB | NF-KB | ncbigene_synonym | NFKB1 | 4790 |
| Homo sapiens | Primates | Sp1 | SP1 | ncbigene_symbol | SP1 | 6667 |
| Homo sapiens | Primates | Sp1 | SP1 | ncbigene_synonym | PSG1 | 5669 |
| Homo sapiens | Primates | Sp1 | SP1 | ncbigene_synonym | DAND5 | 199699 |
| Homo sapiens | Primates | Tcf | TCF | ncbigene_synonym | HNF4A | 3172 |
| Homo sapiens | Primates | TRAIL | TRAIL | ncbigene_synonym | TNFSF10 | 8743 |
| Homo sapiens | Primates | cyclinD1 | CCND1 | ncbigene_symbol | CCND1 | 595 |
| Homo sapiens | Primates | hnRNPA1 | HNRNPA1 | ncbigene_symbol | HNRNPA1 | 3178 |
| Homo sapiens | Primates | c-myc | C-MYC | ncbigene_synonym | MYC | 4609 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| Ras | RAS | (1R)-N-(prop-2-yn-1-yl)indan-1-amine | chebi:63620 | |
| MEK | MEK | butan-2-one | chebi:28398 | |
| Esculetin | esculetin | esculetin | chebi:490095 | |
| PERK | PERK | tetrachloroethene | chebi:17300 | |
| Esculetin | esculetin | esculetin | chebi:490095 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|---|---|---|---|
| Cancer | cancer | cancer | DOID:162 |